Elsevier

Clinical Lung Cancer

Volume 14, Issue 2, March 2013, Pages 96-102
Clinical Lung Cancer

Review
The Effect of Preoperative Smoking Cessation or Preoperative Pulmonary Rehabilitation on Outcomes After Lung Cancer Surgery: A Systematic Review

https://doi.org/10.1016/j.cllc.2012.07.003Get rights and content

Abstract

The preferred treatment for lung cancer is surgery if the disease is considered resectable and the patient is considered surgically fit. Preoperative smoking cessation and/or preoperative pulmonary rehabilitation might improve postoperative outcomes after lung cancer surgery. The objectives of this systematic review were to determine the effectiveness of (1) preoperative smoking cessation and (2) preoperative pulmonary rehabilitation on peri- and postoperative outcomes in patients who undergo resection for lung cancer. We searched MEDLINE, PreMedline, Embase, Cochrane Library, Cinahl, BNI, Psychinfo, Amed, Web of Science (SCI and SSCI), and Biomed Central. Original studies published in English investigating the effect of preoperative smoking cessation or preoperative pulmonary rehabilitation on operative and longer-term outcomes in ≥ 50 patients who received surgery with curative intent for lung cancer were included. Of the 7 included studies that examined the effect of preoperative smoking cessation (n = 6) and preoperative pulmonary rehabilitation (n = 1) on outcomes after lung cancer surgery, none were randomized controlled trials and only 1 was prospective. The studies used different smoking classifications, the baseline characteristics differed between the study groups in some of the studies, and most had small sample sizes. No formal data synthesis was therefore possible. The included studies were marked by methodological limitations. On the basis of the reported bodies of evidence, it is not possible to make any firm conclusions about the effect of preoperative smoking cessation or of preoperative pulmonary rehabilitation on operative outcomes in patients undergoing surgery for lung cancer.

Introduction

Lung cancer is a disease with a notoriously low overall survival rate because patients often present with locally-advanced or distant disease and the effectiveness of the available treatments is less than optimal. Treatment of choice for stage I and II lung cancer is resection in surgically fit patients, and gives them the only realistic chance of a cure. Long-term survival in these patients can be well over 70% in some series1, 2, 3, 4 and it is important to ensure that as many patients as possible have a chance of having their cancer removed.

The focus of this report is to examine the effectiveness of different interventions in improving outcomes during and after surgical resection of lung cancer. Specifically, we report here 2 systematic reviews of the effect of preoperative smoking cessation and of preoperative pulmonary rehabilitation, respectively, on postoperative outcomes of lung cancer surgery.

Most patients presenting for lung cancer surgery are either current smokers or have a history of smoking. In addition to the long-term adverse effect of smoking on survival, smoking or a history of smoking might also negatively influence the success of pulmonary surgery because of an increased rate of peri- or postoperative pulmonary complications (eg, references 5, 6, 7, 8; but see reference 9) which might be linked to frequently occurring consequences of smoking such as increased sputum production, reduced forced expiratory volume in the first second of expiration (FEV1), chronic bronchitis, or chronic obstructive pulmonary disease (COPD). However, before any recommendations can be made about delaying lung cancer treatment by resection in smokers to allow smoking cessation to take place, there would need to be good evidence that smoking cessation during the delay results in improved outcomes.

Ideally, this evidence would come from well-conducted randomized controlled trials (RCTs) comparing randomly selected groups of patients who have ceased smoking within set preoperative time periods to (1) randomly selected patients who did not cease smoking before resection to examine the effect of preoperative smoking cessation on lung cancer surgical outcomes, and to (2) each other to examine whether time elapsed between smoking cessation and resection influences the peri- or postoperative outcomes. It is, however, unlikely that such studies would be conducted as all the emphasis is on rapid access to treatment and patients are likely to be reluctant to accept delays. It is therefore necessary to systematically examine the results of studies of less ideal designs in order to achieve an indication of the effect of preoperative smoking cessation on outcomes after lung cancer surgery and that way evaluate whether further prospective research in this area is warranted.

Lung function in patients presenting for lung cancer surgery is often reduced preoperatively (eg, because of smoking) and is certainly reduced postoperatively by virtue of the intervention itself. Reduced lung function is associated with a number of complications including death. It is therefore a requirement for surgical candidates that they have adequate lung function preoperatively which is also not predicted to be unsustainably reduced postoperatively. Full or as full as possible preoperative lung function would therefore seem optimal in lung cancer surgical candidates.

Pulmonary rehabilitation constitutes an intervention that serves to restore a patient's lung function to the fullest potential possible. Thus, pulmonary rehabilitation before lung cancer surgery is potentially an attractive technique for optimizing preoperative lung function and conceivably, in turn, reducing postoperative respiratory complications.

In practice, it is often the patients with the lowest pulmonary reserve who are selected for pulmonary rehabilitation. It is, however, not unlikely that a wider spread of lung cancer surgery candidates would benefit from preoperative pulmonary rehabilitation in terms of improved short- and long-term surgical outcomes.

As was the case for the evidence relating to the effect of preoperative smoking cessation on peri- and postoperative outcomes, the ideal evidence for (or against) preoperative pulmonary rehabilitation would come from well-conducted RCTs, in this case, comparing the outcomes after lung cancer surgery between randomly selected groups of patients who have either received preoperative pulmonary rehabilitation or who have not received this preoperative intervention. However, similarly to the case of preoperative smoking cessation, it is unlikely that such studies would be conducted for the same reason, namely the introduction of a potentially unacceptable delay. It will therefore be necessary to systematically examine studies that have either provided preoperative pulmonary rehabilitation in the time period that comprises the natural work-up of a patient for surgery or studies of less controlled designs than RCTs in order to gain an indication of the effect of preoperative pulmonary rehabilitation on outcomes after lung cancer surgery.

The objectives of this study were (1) to systematically examine the effect of preoperative smoking cessation on peri- and postoperative outcomes in patients who undergo resection for lung cancer, and (2) to systematically examine the effect of preoperative pulmonary rehabilitation on peri- and postoperative outcomes in patients who undergo resection for lung cancer.

Section snippets

Criteria for Considering Studies in this Review

We included full-text publications of any original study published in English and investigating the effect of preoperative smoking cessation or preoperative pulmonary rehabilitation on operative and longer-term outcomes in ≥ 50 patients who received surgery with curative intent for lung cancer.

Search Methods for Identification of Studies

The following databases were searched: MEDLINE (1948–September 29, 2011), PreMedline (September 28, 2011), Embase (1980–September 29, 2011), Cochrane Library (September 29, 2011), Cinahl (1982–September

Search Results

The search identified 7 reports which were included in the present reviews: 6 of the 7 reports met the inclusion criteria for the systematic review on preoperative smoking cessation10, 11, 12, 13, 14, 15 and 1 report met the inclusion criteria for the systematic review on preoperative pulmonary rehabilitation16 (see also Figure 1).

Preoperative Smoking Cessation

Barrera et al10 prospectively examined in 300 thoracic surgical patients with primary (n = 221) or secondary (n = 79) lung tumors whether postoperative pulmonary

Preoperative Smoking Cessation

Of the 6 included studies that examined the effect of preoperative smoking cessation on outcomes after surgery for lung cancer, none were RCTs and only 1 was prospective. Furthermore, the studies tended to differ in their classifications of smoking categories. On this basis alone even without considering the results, it is therefore not possible to make any firm conclusions about the effect of preoperative smoking cessation on operative outcomes in patients undergoing surgery for lung cancer.

Implications for Practice

Patients with lung cancer are almost universally current or ex-smokers and professionals who are charged with advising them about the safety and efficacy of surgical treatment often have concerns that their smoking history might cause a higher incidence of postoperative complications. This concern might be the deciding factor in whether or not a patient is thought to be suitable for lung cancer surgery—clearly, a huge decision for a patient suffering from such a serious disease. There is also

Disclosure

All authors have no conflicts of interest.

Acknowledgments

This article presents an extension to 2 systematic reviews undertaken as part of the 2011 National Institute for Health and Clinical Excellence (NICE) guideline on ‘The Diagnosis and Treatment of Lung Cancer (Update)' (available at: http://www.nice.org.uk/guidance/index.jsp?action=byID&o=13465) which was developed by the National Collaborating Centre for Cancer (NCC-C). The NCC-C receives funding from NICE.

The authors thank NICE, the National Collaborating Centre for Cancer, and the Guideline

Cited by (26)

  • Lung Cancer Book—Prehabilitation Chapter

    2022, Lung Cancer Rehabilitation
  • Second Primary Non–Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients

    2020, Clinical Lung Cancer
    Citation Excerpt :

    Smoking is an independent risk factor for HNC and NSCLC. The importance of smoking cessation in the NSCLC patient population has been established and contributes to improved NSCLC outcomes.19-22 It is less clear if smoking cessation after HNC decreases incidence or modifies outcomes in those who develop second primary NSCLC.

  • Bronchial carcinoma and tobacco: An update

    2019, Revue des Maladies Respiratoires
  • Assessment and Optimisation of Lung Cancer Patients for Treatment with Curative Intent

    2016, Clinical Oncology
    Citation Excerpt :

    In addition, smoking cessation at the time of lung cancer diagnosis will probably positively affect future respiratory health, reducing the likelihood of disease recurrence or development of further cancers [79]. To date, there are no randomised controlled studies examining the effect of smoking cessation before surgery [80]. However, multiple studies have shown that patients with a smoking history (current or ex-smokers) have increased postoperative mortality and morbidity compared with never-smokers [81–85].

View all citing articles on Scopus
View full text